{"id":"W7117298964","doi":"10.1016/j.iotech.2025.101461","title":"262P EGFR mutations (EGFR+) or ALK rearrangements (ALK+) in the BR31 trial of adjuvant durvalumab (D) v placebo (P)","year":2025,"lang":"en","type":"article","venue":"Immuno-Oncology Technology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Canadian Cancer Society; Dalhousie University; University of Ottawa","funders":"","keywords":"Durvalumab; Placebo; Adjuvant; Mutation; Clinical trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008306024,0.0008087553,0.001516958,0.0001410377,0.000201732,0.0007880687,0.0004433062,0.0007949807,0.004417596],"category_scores_gemma":[0.0007130791,0.0003380089,0.0008345001,0.0001461381,0.0006157972,0.0007584467,0.0002160514,0.002204323,0.0006774647],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005694841,"about_ca_system_score_gemma":0.0007318858,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00108388,"about_ca_topic_score_gemma":0.003029534,"domain_scores_codex":[0.9996294,0.0001652474,0.00001478311,0.00005484944,0.00002203551,0.0001137138],"domain_scores_gemma":[0.9997697,0.00006195532,0.00003410097,0.00002204133,0.000009822689,0.0001024082],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.9401875,0.002655433,0.001216884,0.000269739,0.0005604104,0.00008696853,0.00004107727,0.0005725625,0.01036331,0.000582334,0.002600257,0.04086368],"study_design_scores_gemma":[0.8185521,0.1562403,0.01164594,0.0001151655,0.001010528,0.0003126891,0.00007887981,0.002023792,0.003272583,0.001065615,0.005644627,0.00003776064],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9885203,0.004743162,0.0003328676,0.001190406,0.0004703224,0.0002337003,0.0005660235,0.00006906875,0.003874186],"genre_scores_gemma":[0.9939579,0.001165177,0.0003205305,0.000528346,0.0001499023,0.0001084032,0.000503234,0.00001052057,0.003256112],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004417596,"threshold_uncertainty_score":0.01477832,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01786102216622019,"score_gpt":0.3937564791857949,"score_spread":0.3758954570195747,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}